AOCNP Exam Prep: Advanced Oncology Certified Nurse Practitioner (ONCC) Study Guide + 2,000+ Practice Questions

A 58-year-old male survivor of head and neck cancer who is 5 years post-treatment with surgery and radiation therapy reports increasing difficulty with swallowing dry foods and a persistent “cotton-mouth” sensation. On exam, he has multiple new dental caries despite good hygiene. What is the most appropriate management strategy?

A patient undergoing intensive therapy for a hematologic malignancy experiences a significant decline in functional status, requiring assistance with most activities of daily living. The family is overwhelmed and struggling to provide care at home. Which multidisciplinary action should the oncology nurse practitioner initiate?

A 45-year-old patient with a newly diagnosed advanced malignancy is identified as having high financial toxicity and low health literacy. The treatment plan involves multiple weekly visits to the cancer center located two hours away. Which coordination intervention is most effective for this patient?

During a multidisciplinary tumor board meeting, a disagreement arises between the radiation oncologist and the surgical oncologist regarding the sequencing of care for a patient with a borderline resectable tumor and marginal performance status. Which role should the oncology nurse practitioner assume to resolve this conflict?

A patient with a history of head and neck cancer has completed intensive local therapy and now presents with severe trismus, dysphagia, and significant unintentional weight loss. The patient is frustrated by the number of different appointments required for recovery. How should the oncology nurse practitioner streamline the multidisciplinary approach for this survivor?

A 54-year-old patient is transitioning to home after an extensive pelvic exenteration. The patient has a new urinary diversion, a colostomy, and a complex surgical wound requiring frequent dressing changes. The patient lives alone in a rural area and expresses concern about managing these changes. Which strategy should the oncology nurse practitioner prioritize to ensure a safe transition?

A 68-year-old patient with a history of poorly controlled type 2 diabetes and congestive heart failure is diagnosed with a complex gastrointestinal malignancy requiring major surgical resection. The surgical team is concerned about perioperative morbidity, while the patient is anxious about losing independence. Which action by the oncology nurse practitioner best facilitates multidisciplinary coordination for this patient?

A 62-year-old female received pelvic radiation therapy twenty years ago for the treatment of cervical cancer. She is currently asymptomatic and follows up for general health maintenance. When discussing cancer screening, which consideration is most important for this patient?

A 35-year-old female underwent a loop electrosurgical excision procedure (LEEP) for cervical intraepithelial neoplasia grade 3 (CIN 3) five years ago. Her subsequent follow-up tests were negative. She is now presenting for her routine well-woman exam. Which screening protocol is required for this patient?

A 52-year-old male was diagnosed with extensive ulcerative colitis twelve years ago. He has been in clinical remission for three years. He asks about his colorectal cancer screening needs compared to his peers who are just starting their first screenings. Which strategy should be implemented for this patient?

A 45-year-old female with no family history of breast cancer undergoes a screening mammogram. The radiologist reports the breast tissue as heterogeneously dense (BI-RADS Category C). The patient expresses concern about the accuracy of the results and asks about the next steps for her screening routine. Which recommendation is most consistent with current evidence?

A 68-year-old male presents for a wellness visit. He smoked one pack of cigarettes daily for forty years and successfully quit twelve years ago. He has no history of chest pain or weight loss but reports a mild, chronic morning cough. Which screening strategy is most appropriate for this patient based on current evidence-based guidelines?

A 38-year-old male survivor of testicular cancer who was treated with multi-agent systemic therapy and retroperitoneal lymph node dissection 10 years ago presents for a survivorship follow-up. He expresses concern about his risk for metabolic syndrome and cardiovascular disease. Which set of assessments is most relevant for this patient?

A 29-year-old female survivor of a childhood CNS tumor presents with concerns about her ability to manage her finances and organize her daily schedule. She completed multi-modal therapy, including cranial radiation, 15 years ago. She has no focal neurological deficits. Which action should the nurse practitioner take?

A 62-year-old male with a 40 pack-year smoking history presents with a new cough and a 3-centimeter peripheral right upper lobe lung mass identified on computed tomography. A subsequent positron emission tomography scan demonstrates intense uptake in the primary mass and a 1.2-centimeter ipsilateral mediastinal lymph node, while the contralateral hilar and supraclavicular regions show no metabolic activity. Which diagnostic procedure is most appropriate to accurately determine the clinical stage and guide the subsequent surgical treatment plan?

A 64-year-old female survivor of pelvic malignancy who received external beam radiation therapy and long-term hormone-deprivation therapy reports new-onset, localized dull aching in her lower back and hips. She has no history of trauma. Which diagnostic step is most appropriate to evaluate for late effects of treatment?

A 32-year-old female survivor of pediatric lymphoma was treated with mantle field radiation at age 19. She is now establishing care in a survivorship clinic. She has no family history of breast cancer and no palpable masses on exam. Which breast cancer screening strategy should the nurse practitioner implement?

A 45-year-old male survivor of Hodgkin lymphoma who received mediastinal radiation 15 years ago presents for a routine survivorship visit. He is currently asymptomatic and physically active. According to evidence-based survivorship guidelines for late cardiovascular effects, which intervention is the most appropriate for this patient?

A 30-year-old male is diagnosed with bilateral clear cell renal cell carcinoma. His medical record indicates a previous surgery for a retinal hemangioblastoma during his teenage years. He reports that his father died of a “spinal cord tumor” in his late 40s. Which inheritance pattern and associated risk should the nurse practitioner discuss during the genetic risk assessment?

A 40-year-old female with a history of macrocephaly and benign follicular thyroid nodules is evaluated for a new diagnosis of bilateral breast cancer. Physical examination reveals multiple small, flesh-colored papules on her face and papillomatous lesions on her oral mucosa. Which gene mutation is most likely responsible for this clinical presentation?

A 28-year-old patient with a history of pediatric osteosarcoma presents with a new diagnosis of a brain tumor. The family history is notable for a mother who died of inflammatory breast cancer at age 32 and a maternal uncle with an adrenal cortical carcinoma. Given this constellation of early-onset and rare malignancies, which genetic syndrome should the nurse practitioner primarily investigate?

A 35-year-old male is referred to the oncology clinic after being diagnosed with invasive ductal carcinoma of the breast. He reports that his paternal grandmother died of ovarian cancer at age 50 and a paternal aunt had pre-menopausal breast cancer. He expresses concern about his children’s risks. Which statement best reflects the appropriate genetic risk assessment for this patient based on current clinical guidelines?

A 42-year-old female presents for a routine oncology follow-up after completing treatment for early-stage endometrial cancer. During the visit, she mentions that her brother was diagnosed with colon cancer at age 48 and her father had a history of sebaceous adenomas and early-onset gastric cancer. Based on this family history and her personal diagnosis, which action should the nurse practitioner prioritize to assess for a specific hereditary cancer syndrome?

A 42-year-old male with a newly diagnosed 2.5-centimeter malignant melanoma on his left calf, with a Breslow thickness of 2.1 millimeters and presence of ulceration, is being staged. Physical examination reveals no palpable inguinal lymphadenopathy. Which diagnostic step is most appropriate to determine the presence of regional nodal involvement for accurate pathological staging?

A 72-year-old patient with a history of chronic hepatitis C is found to have a 2.5-centimeter lesion in the right lobe of the liver during routine surveillance. The alpha-fetoprotein level is 450 ng/mL, and a dynamic contrast-enhanced magnetic resonance imaging scan shows arterial phase hyperenhancement followed by venous phase washout. How should the nurse practitioner interpret these findings within the context of staging and diagnosis?

A 49-year-old female presents with a 4-centimeter mass in the tail of the pancreas identified on an ultrasound performed for vague abdominal pain. A subsequent triple-phase computed tomography scan shows the mass is in close contact with the splenic artery but does not involve the celiac axis or the superior mesenteric artery, and there are no visible liver lesions. What is the most critical interpretation of these findings regarding the surgical staging and resectability of the tumor?

A 68-year-old male with newly diagnosed high-risk prostate cancer, characterized by a prostate-specific antigen level of 22 ng/mL and a Gleason score of 8, is being evaluated for distant metastasis. A computed tomography scan of the abdomen and pelvis shows no evidence of lymphadenopathy or visceral disease, but the patient reports intermittent pelvic discomfort. Which imaging modality should be utilized next to complete the staging workup based on the high-risk features and clinical symptoms?

A 55-year-old female with a history of invasive ductal carcinoma of the breast, staged as T2N1M0, is undergoing a systemic evaluation after reporting new, localized persistent pain in her lumbar spine. A bone scan reveals a solitary area of increased radiotracer uptake at the L3 vertebra, while her alkaline phosphatase levels remain within the normal reference range. What is the most appropriate next step to differentiate between a benign process and metastatic progression for accurate restaging?